IMLFF News and Press, InMed Pharmaceuticals Inc. From 03/12/19

TSX:IN OTCQX:IMLFF VANCOUVER , March 12, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoid...

Cannabinoid-based biopharmaceutical company InMed Pharmaceuticals (TSX: IN) (OTCQX: IMLFF) today announced its addition of Dr. Steven M. Dinh to its Scientific Advisory Board. Per the update, Dr. Dinh brings more than 30 years of pharmaceutical and biotech executive leadership, as well as prov...

March 7, 2019 Palm Beach, FL – March 7, 2019 – The Brightfield Group has gotten quite a lot of ink lately… for their projections that the hemp derived CBD market will outpace the “Rest of the cannabis market COMBINED”.  FORBES too took a look back ...

Cannabinoid-based biopharmaceutical company InMed Pharmaceuticals (TSX: IN) (OTCQX: IMLFF) today announced its addition of Dr. Steven M. Dinh to its Scientific Advisory Board. Per the update, Dr. Dinh brings more than 30 years of pharmaceutical and biotech executive leadership, as well as prov...

TSX:IN OTCQX:IMLFF Dinh Fortifies InMed's Development Expertise in Dermatology and Drug Delivery VANCOUVER , March 6, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages i...

CORAL GABLES, FL/ ACCESSWIRE / March 1, 2019 / The marijuana stock market has proven to be something to marvel at over the course of the past few months, as companies in the cannabis sector have been enjoying the market's recent bull run. Perhaps the most update to the industry has been th...

InMed Pharmaceuticals, Inc. (IMLFF) Q2 2019 Results Earnings Conference Call February 12, 2019, 01:00 PM ET Company Participants Josh Blacher - Chief Business Officer Eric Adams - President and CEO Jeff Charpentier - CFO Conference Call Participants Max Jacobs - Edison Grou...

InMed Pharmaceuticals ( OTCQX:IMLFF ): Q2 GAAP EPS of -C$0.02. More news on: InMed Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update Canada NewsWire VANCOUVER, Feb. 12, 2019 ...

CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / The market surrounding marijuana stocks has continued to maintain a significant presence in media conversations when discussing future industries with the potential for exponential growth. Specifically, in North America, many variables ha...